High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
Open Access
- 18 September 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (58) , 98117-98134
Abstract
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancerKeywords
This publication has 40 references indexed in Scilit:
- Genetic Susceptibility Loci, Pesticide Exposure and Prostate Cancer RiskPLOS ONE, 2013
- Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and SulforaphaneJournal of Oncology, 2013
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- AMP-activated protein kinase promotes human prostate cancer cell growth and survivalMolecular Cancer Therapeutics, 2009
- AMP-activated protein kinase and human cancer: cancer metabolism revisitedInternational Journal of Obesity, 2008
- Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional PathwaysCancer Research, 2008
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyThe Lancet Oncology, 2008
- Reorganisation of the dendritic actin network during cancer cell migration and invasionSeminars in Cancer Biology, 2008
- AMP-activated/SNF1 protein kinases: conserved guardians of cellular energyNature Reviews Molecular Cell Biology, 2007
- A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancerGenes & Development, 2006